IDiyas

For the Inventor, By the Inventor

Miltona, MN, United States of America

Robert L Shields

USPTO Granted Patents = 16

Average Co-Inventor Count = 1.3

ph-index = 9

Forward Citations = 790(Granted Patents)


Location History:

  • Newburgh, IN (US) (1996 - 1998)
  • Keyport, NJ (US) (2004)
  • Miltona, MN (US) (1989 - 2005)
  • San Mateo, CA (US) (2001 - 2010)

Company Filing History:

goldMedal2 out of 3,221 
 
Genentech, Inc.
 patents
silverMedal8 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2025

Loading Chart...
16 patents (USPTO):Explore Patents
1. 12296242 - Golf bell (2025-05-13),
2. 7662926 - Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor (2010-02-16),
3. 7655229 - Anti-FC-gamma RIIB receptor antibody and uses therefor (2010-02-02),
4. 6848388 - Quick release fastener for flags and flag staffs (2005-02-01),
5. 6680730 - Remote control of apparatus using computer networks (2004-01-20),
6. 6242195 - Methods for determining binding of an analyte to a receptor (2001-06-05),
7. 5732448 - Stirrup buckle (1998-03-31),
8. D376995 - Stirrup buckle (1996-12-31),
9. 5088562 - Hand aerator (1992-02-18),
10. 4982800 - Sod cutter (1991-01-08),
11. D312543 - End standard for a bench (1990-12-04),
12. 4966238 - Hexagon turf plugger (1990-10-30),
13. 4934464 - Sod cutter (1990-06-19),
14. D306814 - Turf repair tool (1990-03-27),
15. D306247 - Golf green hole auger (1990-02-27),

Title: **The Innovative Journey of Robert L. Shields**

Introduction

Robert L. Shields, based in Miltona, Minnesota, is a remarkable inventor known for his contributions to the field of biotechnology. With 14 patents to his name, he has made significant strides in developing novel antibodies with therapeutic applications. His work has paved the way for advancements in medical treatments and understanding immune responses.

Latest Patents

Among his most notable recent patents are those related to anti-Fc-gamma receptor antibodies and bispecific variants. One patent describes antibodies that selectively bind to human FcγRIIB, demonstrating minimal interaction with other FcγRs such as FcγRIIA. This invention also includes isolated bispecific antibodies that consist of one antibody targeting FcγRIIB and another specifically engaging an activating receptor. These innovations explore various therapeutic uses, including the administration of anti-tumor antibodies, methods to inhibit immune responses, and techniques for suppressing histamine release. Another patent similarly emphasizes the potential of these antibodies in therapeutic contexts, showcasing the breadth of application for his inventions.

Career Highlights

Robert L. Shields has contributed significantly to the field of immunology and therapeutic development throughout his career. His efforts have been recognized industry-wide, particularly during his time at companies known for innovative research, such as Genentech, Inc. His work has continuously evolved, reflecting both his dedication and expertise in advancing biomedical science.

Collaborations

Throughout his career, Shields has collaborated with notable professionals, including Andrew C. Chan and Lawren Wu. These partnerships have fueled the innovation and development of groundbreaking technologies in antibody research and therapeutic applications, enriching the scientific community and enhancing research outcomes.

Conclusion

Robert L. Shields stands as a prominent figure in the realm of biotechnology and antibody research. His innovative patents and collaborations mark him as an influential inventor, driving forward the future of medical treatments and the understanding of immune mechanisms. The impact of his work continues to resonate in the field, establishing foundations for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…